MMED

MiniMed Group, Inc. MMED

NasdaqMid CapHealthcare

13F Pro quality score

Rank #2,227 of 2,925

Why it scores 38Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$843.00M

Quarter to Jul 31

Net income

$0

Quarter to Jul 31

Free cash flow

$-90.00M

Quarter to Jul 31

Operating margin

0.6%

Quarter to Jul 31

Top Institutional Holders

as of Q2 2026
$556.89M total
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$124.60M+21.2%
MILLENNIUM MANAGEMENT LLC
$45.76M+18.0%
CITADEL ADVISORS LLC
$42.84M+0.5%
Longaeva Partners L.P.
$42.05M-11.5%
Sessa Capital IM, L.P.
$29.90M0.0%
BlackRock, Inc.
$29.85M+7527.5%
NORGES BANK
$29.32M--
Rock Springs Capital Management LP
$22.72M+44.1%
ExodusPoint Capital Management, LP
$21.48MNew
FMR LLC
$16.16M-20.8%
GEODE CAPITAL MANAGEMENT, LLC
$14.30M+288.7%
Boston Partners
$13.50M+6.8%
J. Goldman & Co LP
$12.41MNew
Nuveen, LLC
$8.06MNew
UBS Group AG
$6.18M+32.8%
STATE STREET CORP
$6.03MNew
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
$5.61M-50.0%
FIRST TRUST ADVISORS LP
$5.48M+269.4%
VANGUARD CAPITAL MANAGEMENT LLC
$4.83MNew
ADAGE CAPITAL PARTNERS GP, L.L.C.
$4.49MNew
Burkehill Global Management, LP
$4.49M0.0%
READYSTATE ASSET MANAGEMENT LP
$4.40M-6.6%
Neuberger Berman Group LLC
$3.96MNew
TUDOR INVESTMENT CORP ET AL
$3.86M+1524.0%
Alberta Investment Management Corp
$3.74M0.0%
See all 98 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q1 2027
EDGAR

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Operating Margin

Q1 2027
EDGAR

ROIC

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MMED

Earnings Per Share

13fpro.ai/company/MMED

Loading ratio trend…

MMED key financials by period

Reported revenue, net income and operating margin by fiscal year, from MiniMed Group, Inc.'s annual filings on SEC EDGAR.

MiniMed Group, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$3.1B$-333.0M-6.1%
FY 2025$2.7B$-213.0M-5.4%
FY 2024$2.5B$-112.0M-2.8%
Source: MMED filings on SEC EDGAR →

Companies similar to MMED

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

MMED insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MiniMed Group, Inc. (MMED): stock profile, AI score and financials

MiniMed Group, Inc. (MMED) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MMED at 37.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,227 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (12.7) and free cash flow (15.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2027), MiniMed Group, Inc. reports quarterly revenue of $843.0M, net income of $0.00, an operating margin of 0.6%. Top institutional holders of MMED by reported 13-F value include MASSACHUSETTS FINANCIAL SERVICES, MILLENNIUM MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. MMED trades on the Nasdaq exchange and files with the SEC under CIK 2062583. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MMED daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MiniMed Group, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2062583 →